Seiko Diane Yamada to Metformin
This is a "connection" page, showing publications Seiko Diane Yamada has written about Metformin.
Connection Strength
0.899
-
Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial. Gynecol Oncol. 2025 Mar; 194:18-24.
Score: 0.816
-
Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity. Obstet Gynecol. 2012 Jan; 119(1):61-7.
Score: 0.082